🚨Mitral Annular Plane Systolic Excursion (MAPSE)🚨
🔴Longitudinal displacement of the mitral valve annulus occurs during systole. This distance of this displacement relative to the apex of the heart can be tracked, measured and used as a marker for LV systolic function.
🔴Either the septal or lateral annulus of the mitral valve can be used for MAPSE. An average of the 2 measurements can be used. The M-Mode cursor is placed over the respective mitral valve annulus.
🔴MAPSE is measured as the distance from the nadir of the M-Mode tracing to the peak
🪧2D apical 4 chamber images are shown in diastole and systole. Longitudinal movement of the annulus during systole is observed. The M-Mode cursor is placed across the lateral annulus of the mitral valve and a tracing of the displacement during systole is obtained and measured.
MAPSE on Echocardiography: A Simple, Powerful Marker of LV Longitudinal Function
Mitral Annular Plane Systolic Excursion (MAPSE) is one of the most under-used yet remarkably useful echocardiographic parameters. It reflects longitudinal shortening of the left ventricle, a motion primarily generated by subendocardial longitudinal fibers—those most vulnerable to ischemia, hypertension, and myocardial disease.
What is MAPSE?
MAPSE measures how far the mitral annulus moves toward the LV apex during systole.
It is obtained in the apical 4-chamber view using M-mode aligned over the septal and lateral mitral annulus.
Because longitudinal fibers are affected early in many diseases, MAPSE often falls before EF drops, making it a sensitive marker of early LV dysfunction.
---
How to Measure MAPSE
1. Get a clear A4C view.
2. Place M-mode cursor exactly through the mitral annulus (septal and then lateral).
3. Measure the total systolic displacement from the annular peak in diastole to its peak in systole.
4. Average septal + lateral = Global MAPSE.
---
Normal Values
Region Normal Mild ↓ Moderate ↓ Severe ↓
Septal MAPSE >7 mm 6–7 mm 4–6 mm <4 mm
Lateral MAPSE >10 mm 8–10 mm 6–8 mm <6 mm
Average (Global) ≥10 mm 8–10 mm 6–8 mm <6 mm
Age reduces MAPSE slightly due to declining longitudinal mechanics.
---
Clinical Uses of MAPSE
1. Early Detection of LV Dysfunction
MAPSE decreases before EF declines, especially in:
Hypertension
Diabetes
CAD/ischemia
Amyloidosis
Chemotherapy-related cardiotoxicity
HFpEF
2. Quick Bedside Assessment in Critical Care
MAPSE is fast, reproducible, and less load-dependent than EF.
Useful in:
Shock (sepsis, cardiogenic shock)
ICU patients
Limited acoustic windows
3. Assessment of Longitudinal Function in HFpEF
HFpEF patients often have normal EF but reduced longitudinal strain and reduced MAPSE.
4. Prognostic Marker
Low MAPSE correlates with increased mortality in:
Acute coronary syndrome
Heart failure
Post–cardiac surgery patients
---
How to Interpret MAPSE
High MAPSE
Hyperdynamic LV (sepsis, anemia, fever)
Early compensated states
Low MAPSE
LV systolic dysfunction (global or regional)
Subendocardial ischemia
Infiltrative cardiomyopathies (amyloidosis → especially low “septal MAPSE”)
RV pressure overload (can reduce septal MAPSE due to septal tethering)
Aging
---
MAPSE vs GLS vs EF
Parameter Strengths Limitations
MAPSE Fast, simple, reproducible; good for low-quality images; reflects longitudinal function Angle-dependent; only longitudinal mechanics
GLS Most sensitive marker of LV systolic dysfunction Requires good image quality + speckle tracking
EF Common and widely understood Load-dependent, may appear normal in early disease
MAPSE is excellent for quick assessment and early detection, while GLS offers richer detail and EF provides traditional global function.
---
When MAPSE Is Most Useful (Real-World)
When images are poor
When strain software is unavailable
Rapid assessment in ER/ICU
Tracking subtle change in cardiotoxicity patients
Evaluating LV function in HFpEF patients
Infiltrative cardiomyopathy (septal MAPSE often strikingly low)
---
Bottom Line
MAPSE is a simple, powerful, and often overlooked marker of LV longitudinal systolic function. It adds significant value to routine echo, especially where GLS or high-quality images are not available. A quick MAPSE measurement can detect dysfunction earlier than EF, improve risk stratification, and guide management in both acute and chronic cardiac conditions.

Comments
Post a Comment
Drop your thoughts here, we would love to hear from you